Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2025-12-28 @ 5:31 PM
Study NCT ID:
NCT00396968
Status:
WITHDRAWN
Last Update Posted:
2014-02-11
First Post:
2006-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2006-11-06
First Submit QC Date:
None
Study First Post Date:
2006-11-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-10
Last Update Post Date:
2014-02-11
Last Update Post Date Type:
ESTIMATED